|
|
Article: LifeSpan BioSciences to Release 20,000 Immunohistochemistry-Validated Reagent Antibodies.
- Article from:
- Business Wire
- Article date:
- June 12, 2008
|
Copyright informationCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Leader in Antibody Evaluation and Validation Expands Focus to Include Development and Sales of Antibodies Validated for Use in Immunohistochemistry
SEATTLE -- LifeSpan BioSciences, Inc., today announced an initiative to release 20,000 immunohistochemistry-validated reagent antibodies over the next four years. The leader in immunohistochemistry (IHC) antibody validation research since 1995, LifeSpan expanded its product focus to include the development and sale of IHC-validated antibodies in Q4 2006. To date, LifeSpan has built a catalog of more than 37,000 reagent antibodies, including more than 2,000 antibodies validated for use in immunohistochemistry. The company ...
Related newspaper, magazine, and journal articles:
|
|
Article: PFIZER BECOMES SUBSCRIBER TO GPCR LACALIZATION DATABASE.
Worldwide Databases;
April 1, 2000 ;
549 words
...LifeSpan BioSciences, Inc., Seattle, Wash., a biotechnology...Brown, president and CEO of LifeSpan BioSciences. LifeSpan provides its subscribers...LifeSpan's chief scientific officer. LifeSpan BioSciences, headquartered in Seattle...
|
|